You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DEPEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Depen, and when can generic versions of Depen launch?

Depen is a drug marketed by Mylan Speciality Lp and is included in one NDA.

The generic ingredient in DEPEN is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Depen

A generic version of DEPEN was approved as penicillamine by WATSON LABS INC on June 24th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEPEN?
  • What are the global sales for DEPEN?
  • What is Average Wholesale Price for DEPEN?
Summary for DEPEN
Drug patent expirations by year for DEPEN
Drug Prices for DEPEN

See drug prices for DEPEN

Pharmacology for DEPEN

US Patents and Regulatory Information for DEPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp DEPEN penicillamine TABLET;ORAL 019854-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.